MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2022-23)
- Udyam number
- UDYAM-TS-20-0003007
KRS Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹54.79 Cr
▲ 60% YoY
Net profit · FY 2025
₹16.13 Lakh
Net margin 0.3%
EBITDA · FY 2025
₹3.27 Cr
EBITDA margin 6%
Authorised capital
₹8.46 Cr
Registered with MCA
Paid-up capital
₹6.73 Cr
Issued & subscribed
Open charges
₹22.51 Cr
Satisfied ₹9.55 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
55
Provident fund records
About KRS Pharmaceuticals Private Limited
Data last updated:
KRS Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 12 September 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2000PTC035234. Its GSTIN is 36AABCK4657M1Z4 (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹8.46 Cr and a paid-up capital of ₹6.73 Cr. It is led by directors including Lakshmana Swamy Balusu (Managing Director) and Narendra Balusu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.44 Co – Operative Industrial Estate Gandhi Nagar Balanagar, Hyderabad, Telangana, India – 500037.
As per the financials filed for FY 2025, the company reported a revenue of ₹54.79 Cr, a growth of 60% compared to the previous year. For the same year it recorded a net profit of ₹16.13 Lakh (net margin 0.3%) and EBITDA of ₹3.27 Cr (EBITDA margin 6%). Revenue has grown at a compounded annual rate (CAGR) of 1% over five years.
The company has about 55 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: KRS Pharmaceuticals. As per MCA filings, the company has open charges of ₹22.51 Cr and satisfied charges of ₹9.55 Cr on record. Court records list 7 cases involving the company, including 6 filed by the company and 1 filed against it; 1 case is pending. The company has 8 deals on record (4 funding rounds, 4 secondary share transfers), with disclosed funding of ₹7.03 Cr; the latest was in March 2021.
KRS Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0003007). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website krspharma.com.
Company details
CIN U24239TG2000PTC035234
Registration Number 035234
Incorporation Date 12 September 2000
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-20-0003007
CIN history
KRS Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239AP2000PTC035234. The current CIN is U24239TG2000PTC035234, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2000PTC035234 | Current |
| U24239AP2000PTC035234 | Previous |
Key People
Lakshmana Swamy Balusu Managing Director Narendra Balusu Director Sai Phani Teja Balusu Director Recognitions & Rankings of KRS Pharmaceuticals
Contact details
KRS Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is krspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.44 Co – Operative Industrial Estate Gandhi Nagar Balanagar, Hyderabad, Telangana, India – 500037
- IndustryPharma, API Manufacturers
To see the full contact details of KRS Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
KRS Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
KRS Pharmaceuticals operates one associated brand: KRS Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures chemicals and intermediates while providing contract research services for the pharmaceutical industry. | krspharma.com |
Business activity
The main business activity of KRS Pharmaceuticals is hospital and medical care. In detail, this covers hospital activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities |
To see the full business activity and turnover split of KRS Pharmaceuticals Private Limited, buy the company report.
Financials of KRS Pharmaceuticals Private Limited
FY 2025 filings availableKRS Pharmaceuticals Private Limited reported revenue of ₹54.79 Cr (up 60% YoY) for FY 2025.
Revenue · FY 2025
₹54.79 Cr ▲ 60%
Net profit · FY 2025
₹16.13 Lakh margin 0.3%
EBITDA · FY 2025
₹3.27 Cr margin 6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 60%
5 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▼ 4%
3 years · compounded
▼ 19%
5 years · compounded
▼ 9%
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 60% growth in the latest year. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.27 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16.13 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of KRS Pharmaceuticals Private Limited, buy the company report.
Board of directors of KRS Pharmaceuticals Private Limited
KRS Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lakshmana Swamy Balusu | Managing Director | 12 Sep 2000 | 26 Years 1 Months | Current |
| Narendra Balusu | Director | 27 Aug 2004 | 22 Years 1 Months | Current |
| Sai Phani Teja Balusu | Director | 13 Oct 2021 | 5 Years 0 Months | Current |
| Koneru Chiranjivee Rammohan Rao | Director | 02 Nov 2009 | 16 Years 11 Months | Current |
Auditor
KRS Pharmaceuticals Private Limited is audited by DARAPANENIANDCO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DARAPANENIANDCO | FY 2023 | 000685S |
Shareholding
The shareholding of KRS Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of KRS Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹22.51 Cr
Satisfied charges
₹9.55 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Dec 2023 | 100872415 | Others | ₹4.98 Cr | Open | |
| 27 Jun 2023 | 100766026 | Others | ₹9.1 Cr | Open | |
| 29 Sep 2020 | 100475355 | Axis Bank Limited | ₹14.3 Lakh | Open | |
| 22 Feb 2018 | 100172579 | Others | ₹8.29 Cr | Open | |
| 12 Jan 2009 | 10138147 | State Bank of India | ₹8.56 Cr | Satisfied |
To see the full charge records of KRS Pharmaceuticals Private Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
KRS Pharmaceuticals Private Limited has 8 deals on record (4 funding rounds, 4 secondary share transfers), with disclosed funding of ₹7.03 Cr; the latest was in March 2021.
Total deals
8
Funding rounds
4
Secondary share transfers
4
Disclosed funding
₹7.03 Cr
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Funding round | ₹69 Lakh | Investors: 2 individuals |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 3 individuals |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Pink Estates Pvt Ltd , 3 individuals |
| Mar 2012 | Funding round | ₹3.93 Cr | Investors: Ocean Pharmacoat Private Limited , 3 individuals |
| Mar 2010 | Funding round | ₹1.67 Cr | Investors: Pink Estates Pvt Ltd , 3 individuals |
To see the full deal history of KRS Pharmaceuticals Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
KRS Pharmaceuticals Private Limited has 7 court cases on record: 6 filed by KRS Pharmaceuticals, 1 filed against it. 1 case is pending and 6 are disposed.
Total cases
7
Filed by the company
6
Filed against the company
1
Pending
1
Disposed
6
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 0 | 1 |
| District courts | 2 | 1 | 0 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd., and 1 other | Disposed |
| High Court, TELANGANA | Writ petition | Filed by the company against M/S. Vinay Chem Pharma Limited and 5 others | Disposed |
| High Court, TELANGANA | Writ petition | Filed by the company against Assistant Commissioner of Central Tax, and 1 other | Pending |
| District court, Rangareddy, Telangana | Execution petition | Filed against the company by M/S. Samarath Engineers, Repby Rajesh Phadke, S/O. Late K.N. Phadke | Disposed |
| District court, Hyderabad CCC, Telangana | Court case (AS) | Filed by the company against M/S Samarth Engineers Proprietary Concern. | Disposed |
To see the full case history of KRS Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
KRS Pharmaceuticals Private Limited was last rated by Crisil on 13 Nov 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 13 Nov 2020 |
To see the full credit ratings and regulatory alerts of KRS Pharmaceuticals Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for KRS Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
KRS Pharmaceuticals Private Limited has a workforce of 55 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
55
Active EPFO establishments
1
Employee growth
-17.91%
GST
KRS Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCK4657M1Z4 | Telangana | Active | 01 Jul 2017 |
| 37AABCK4657M1Z2 | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of KRS Pharmaceuticals Private Limited, buy the company report.
Recent activity
KRS Pharmaceuticals Private Limited has 5 board changes on record since 2000: 4 appointments and 1 cessation. The latest: Sai Phani Teja Balusu was appointed as Director on 13 Oct 2021.
AGM
Krs Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Krs Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Others of Rs. 9.10 Cr registered on 27 Jun 2023 with Charge ID 100766026 was modified on 31 Jan 2025.
Charges
A charge with Others amounted to Rs. 4.98 Cr with Charge ID 100872415 was registered on 29 Dec 2023.
Charges
A charge with Others amounted to Rs. 9.10 Cr with Charge ID 100766026 was registered on 27 Jun 2023.
Appointed
Sai Phani Teja Balusu was appointed as Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.14 Cr with Charge ID 100475355 was registered on 29 Sep 2020.
Charges
A charge with Others of Rs. 8.29 Cr registered on 22 Feb 2018 with Charge ID 100172579 was modified on 24 Dec 2019.
Charges
A charge registered on 12 Jan 2009 via Charge ID 10138147 with State Bank Of India was fully satisfied on 23 Apr 2018.
Charges
A charge with Others amounted to Rs. 8.29 Cr with Charge ID 100172579 was registered on 22 Feb 2018.
Charges
A charge with State Bank Of India of Rs. 8.56 Cr registered on 12 Jan 2009 with Charge ID 10138147 was modified on 07 Nov 2016.
Appointed
Koneru Chiranjivee Rammohan Rao was appointed as Director.
9 earlier events are in the company report.
Frequently asked questions
KRS Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 12 September 2000 (26+ years old) and is registered under CIN U24239TG2000PTC035234.
KRS Pharmaceuticals has 4 current directors:
- Lakshmana Swamy Balusu - Managing Director
- Narendra Balusu - Director
- Sai Phani Teja Balusu - Director
- Koneru Chiranjivee Rammohan Rao - Director
The latest financial statements of KRS Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of KRS Pharmaceuticals is 36AABCK4657M1Z4, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AABCK4657M1Z2 (Andhra Pradesh).
The CIN (Corporate Identification Number) of KRS Pharmaceuticals is U24239TG2000PTC035234. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
KRS Pharmaceuticals has 7 court cases on record: 6 filed by the company and 1 filed against it. 1 is pending. Most are in the high courts.
KRS Pharmaceuticals was incorporated on 12 September 2000, making it 26+ years old. It is registered with the Registrar of Companies, Hyderabad.
KRS Pharmaceuticals has 8 deals on record (4 funding rounds, 4 secondary share transfers), with disclosed funding of ₹7.03 Cr; the latest was in March 2021.
Sai Phani Teja Balusu was appointed as Director on 13 Oct 2021. Koneru Chiranjivee Rammohan Rao was appointed as Director on 02 Nov 2009. Surapanani Veera Kumar Das ceased to be Director on 15 Sep 2008. KRS Pharmaceuticals has 5 board changes on record in total.
Yes, KRS Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-20-0003007).